| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/27/2006 | CN1838942A Compositions and methods for hydrophobic drug delivery |
| 09/27/2006 | CN1837231A Immunomodulatory steroids, in particular the hemihydrate of 16, alpha-bromoepiandrosterone |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | CA2279317C O-sulfated bacterial polysaccharides |
| 09/21/2006 | WO2006098628A1 Oral dosage forms of gemcitabine derivatives |
| 09/21/2006 | WO2005058236A8 Cab molecules |
| 09/21/2006 | WO2005055932A3 Therapeutic combinations and methods including irm compounds |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | WO2005032474A3 Pharmaceutical compositions for prevention of overdose or abuse |
| 09/21/2006 | WO2004110386A3 Molecular interaction sites of coronavirus rna and methods of modulating the same |
| 09/21/2006 | WO2004093802A3 Prevention of deficits in neurogenesis with anti-inflammatory agents |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060211758 M3 muscarinic acetylcholine receptor antagonists |
| 09/21/2006 | US20060211727 Novel compounds |
| 09/21/2006 | US20060211712 E.g., 6'-Chloro-3-methyl-5'-{[2-(2-oxo-3-pyridin-2-yl-2,3-dihydro-1H-benzimidazol-1-yl)acetyl]amino}-spiro[imidazolidine-4,2'-indane]-2,5-dione; treating migraines and cluster headaches optionally with serotonin agonists, analgesics, anti-inflammatory agents, anti-hypertensives and/or anticonvulsants. |
| 09/21/2006 | US20060211687 Potassium salt of an hiv integrase inhibitor |
| 09/21/2006 | US20060211682 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211641 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 09/21/2006 | US20060211624 Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies |
| 09/21/2006 | US20060211610 Controlling biological activities such as cell proliferation, nutrient transport, lipolysis and intestinal water and electrolyte secretion; PYY agonists: obesity, antidiabetic agents, eating disorders; cardiovascular diseasse; PYY antagonist: facilitating weight gain and appetite increase |
| 09/21/2006 | US20060210654 Process for extracting vital components from plants |
| 09/21/2006 | US20060210633 Programmed drug delivery system |
| 09/21/2006 | US20060210568 Methods and compositions for cancer treatment |
| 09/21/2006 | US20060210486 Aerosol antiperspirant with polyamide |
| 09/21/2006 | CA2600399A1 Oral dosage forms of gemcitabine derivatives |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1701733A1 Surface protection of exposed biological tissues |
| 09/20/2006 | EP1701687A2 Quinoa protein concentrate, production and functionality |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | CN1835936A Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/20/2006 | CN1835910A 2-aminobenzoyl derivatives |
| 09/20/2006 | CN1835756A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1835723A Deployable multifunctional hemostatic agent |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/19/2006 | US7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/19/2006 | US7109332 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 09/19/2006 | US7109243 Inhibitors of cathepsin S |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109190 Carbacephem β-lactam antibiotics |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/19/2006 | US7108865 Controlled-release dosage forms of azithromycin |
| 09/14/2006 | WO2005053603A3 Antigen receptor variable region typing |
| 09/14/2006 | WO2005048932A3 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity |
| 09/14/2006 | WO2005037215A3 Compositions and methods for enhancing cognitive function and synaptic plasticity |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2005007114A3 Method of treating diabetes type ii |
| 09/14/2006 | WO2004108066A3 Neuronal regeneration and compound administration methods |
| 09/14/2006 | WO2004098489A3 Compositions and methods for modulation of specific epitopes of hsp60 |
| 09/14/2006 | WO2004078115A3 Benzothiazole compounds, compositions and methods for treatment and prophylaxis of rotavirus infections and associated diseases |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | WO2004037192A3 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/14/2006 | US20060205806 Synergistic combination |
| 09/14/2006 | US20060205765 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents |
| 09/14/2006 | US20060205761 Ccr-2 antagonists for treatment of neuropathic pain |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060204986 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/14/2006 | US20060204967 Methods for identifying risk of breast cancer and treatments thereof |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/14/2006 | US20060204559 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 09/14/2006 | US20060204490 Hemostatic compositions containing sterile thrombin |
| 09/14/2006 | US20060204476 Treating hepatocellular carcinomas using therapeutic viruses |
| 09/14/2006 | US20060204442 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1699490A2 Medical lipolysis of fat accumulations |
| 09/13/2006 | EP1699487A2 Novel anti-dc-sign antibodies |
| 09/13/2006 | EP1699469A2 Recombinant factor viii having increased specific activity |
| 09/13/2006 | EP1699462A1 Reduction of toxicity of multi-targeting antifolates |
| 09/13/2006 | EP1699449A1 Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 09/13/2006 | EP1699431A2 Compositions for treatment of ear disorders and methods of use thereof |
| 09/13/2006 | EP1699366A2 Apparatus and methods for forming and securing gastrointestinal tissue folds |
| 09/13/2006 | EP1664033A4 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 09/13/2006 | EP1620555A4 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 09/13/2006 | EP1578325A4 Stable topical drug delivery compositions |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | EP1094835B1 Process for manufacturing of a pharmaceutical composition comprising human apotransferrin |
| 09/13/2006 | CN1833020A Pro104 antibody compositions and methods of use |
| 09/13/2006 | CN1832959A Polyethelene glycol link glp-1 compounds |
| 09/13/2006 | CN1832956A Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
| 09/13/2006 | CN1832761A Thiotungstate analogues and uses thereof |
| 09/13/2006 | CN1832759A Preventative effects of morinda citrifolia on mammary breast cancer |
| 09/12/2006 | US7105533 3-(3-methoxy-4-(pyridin-2-yl)phenyl)imidazo[1,5-a]pyridine hydrochloride; mGluR5 modulators treating psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, pain |
| 09/12/2006 | US7105530 Pyrimidineamines as angiogenesis modulators |
| 09/12/2006 | US7105516 Compounds for the treatment of premature ejaculation |
| 09/12/2006 | US7105493 Methods and compositions for treating flaviviruses and pestiviruses |
| 09/12/2006 | US7105347 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 09/08/2006 | WO2006041488A8 Immortalized hepatocytes |
| 09/08/2006 | WO2005053619A3 Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal |
| 09/08/2006 | WO2005051307A3 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 09/08/2006 | WO2005051299A3 Metalloproteinase-binding proteins |
| 09/08/2006 | WO2005025517A3 Animal model for protease activity and liver damage |
| 09/08/2006 | WO2004089290A3 Novel probiotic compositions and methods of using the same |
| 09/07/2006 | US20060199177 T helper cell epitopes |
| 09/07/2006 | US20060198892 Polymeric systems for controlled drug therapy |
| 09/07/2006 | US20060198873 Orally dissolving films |
| 09/07/2006 | US20060198836 Method of treating hit patients with argatroban |
| 09/07/2006 | US20060198833 Compositions and methods for targeting a polypeptide to the central nervous system |
| 09/07/2006 | US20060198823 Compositions and methods for treating viral infections |